#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Heavy menstrual bleeding Chronic myeloid leukaemia (in remission) Precursor T-lymphoblastic lymphoma/leukaemia recurrent Isodicentric chromosome 15 syndrome Mixed-type liposarcoma Chondrodystrophy Raynaud's phenomenon Prophylaxis against transplant rejection Neurotrophic keratopathy High-grade B-cell lymphoma Small intestine leiomyosarcoma Hormone-dependent prostate cancer Noonan syndrome Von Hippel-Lindau disease Arteriovenous malformation More trials…

    Learn about Rare Diseases

    Carcinoid syndrome – Trials in Disease Pituitary-dependent Cushing’s syndrome – Diagnostics Ornithine transcarbamoylase deficiency – Life with Disease Glomerulonephritis membranous Piriformis syndrome Toxic epidermal necrolysis – Basic Information Osteosarcoma metastatic – Basic Information Sarcoma – Basic Information Leiomyosarcoma recurrent – Life with Disease Gaucher’s disease type III – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cefuroxime Axetil [18F]Fluoro-Peg-Folate Tasquinimod YL201 Immunoglobulin A VANADIUM OXIDE SULFATE Tiapride Levamisole Hydrochloride Irbesartan Doxribtimine Pimavanserin Tartrate Lenacapavir Nesolicaftor Tofersen Triglycerides, Medium Chain Cannabis Sativa Flower Rosnilimab Propranolol NAVENIBART ZINC More therapies…

    Learn about Your Condition

    Hodgkin's disease Myocardial infarction Skin disorder Neurogenic bladder Acne Cancer fatigue Mastocytosis Hand dermatitis Cystic fibrosis Vertigo Cold type haemolytic anaemia Chronic hepatitis B Polyneuropathy Immune system disorder Suicidal ideation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopitaux Universitaires Pitie Salpetriere

Hopitaux Universitaires Pitie Salpetriere

47 Boulevard De L Hopital, Paris, 75651, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Plixorafenib (FORE8394) for Patients with Cancer Having BRAF Alterations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • BRAF gene mutation
    Investigated Drugs:
    • (3R)-N-[3-[5-(2-Cyclopropylpyrimidin-5-Yl)-1H-Pyrrolo[2,3-B]Pyridine-3-Carbonyl]-2,4-Difluorophenyl]-3-Fluoropyrrolidine-1-Sulfonamide
    • Cobicistat
    France Germany Italy The Netherlands Norway Spain +1

  • Study on Post-Surgery Antibiotic Use for Patients with Biliary Stents Undergoing Pancreaticoduodenectomy: Piperacillin and Tazobactam Evaluation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Tumour of ampulla of Vater
    Investigated Drugs:
    • Piperacillin
    • Piperacillin Monohydrate
    • Piperacillin Sodium
    France

  • Study on Adjusting Adalimumab Dosage for Patients with Rheumatoid Arthritis in Remission

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Adalimumab
    France

  • Study of CAPOX or FOLFOX chemotherapy before surgery in patients with obstructive colon cancer treated with colostomy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Levoleucovorin
    • Capecitabine
    • Fluorouracil
    France

  • Study of Tabelecleucel for Patients with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Transplant Treatment Failure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Epstein-Barr virus associated lymphoproliferative disorder
    • Post transplant lymphoproliferative disorder
    Investigated Drugs:
    • Tabelecleucel
    Austria Belgium France Italy Spain

  • Study on Tabelecleucel for Patients with Epstein-Barr Virus-Associated Diseases

    Recruiting

    2 1 1
    Investigated Diseases:
    • Epstein-Barr virus associated lymphoproliferative disorder
    Investigated Drugs:
    • Tabelecleucel
    Austria Belgium France Italy Spain

  • Study on Atezolizumab and Bevacizumab for Patients with Intermediate-Stage Liver Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    Austria France Germany Italy Spain

  • Study on the Safety of VO659 for Patients with Spinocerebellar Ataxia Types 1, 3, and Huntington’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hereditary ataxia
    • Huntington’s disease
    Investigated Drugs:
    • Vo659
    Denmark France Germany The Netherlands

  • Study of Capecitabine and Pembrolizumab for Patients with Triple Negative Breast Cancer After Chemoimmunotherapy and Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Capecitabine
    • Pembrolizumab
    France

  • Chemotherapy Dose Adjustment for Gastrointestinal Cancer Patients with DPD Deficiency Using Fluorouracil, Capecitabine, and Oxaliplatin

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrointestinal cancer metastatic
    Investigated Drugs:
    • Folinic Acid
    • Capecitabine
    • Fluorouracil
    France
Previous Page
1 2 3 4 5 6 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!